drugset / Trial / NCT07867223

Nanoparticle-Based Prunus Salicina Extract vs. Clotrimazole for Otomycosis

NCT07867223 ↗

Recruiting 180 enrolled Deraya University
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled superiority trial evaluates the anti-otomycotic efficacy of Prunus salicina methanolic extract in two formulations (standard drops and chitosan nanoparticle-based drops) compared to standard 1% clotrimazole drops in patients diagnosed with otomycosis.

Timeline

Start
2025-07-15
Primary completion
2026-11-01
Completion
2026-11-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clotrimazole Unknown 1 % Topical
Subject Prunus salicina extract Unknown — Topical
Subject Prunus salicina methanolic extract Unknown — Topical

Indications